The latest smartwatch from Apple has garnered significant attention thanks to its stylish redesign and the introduction of a sleep apnea detection feature. However, as the launch of the Apple Watch Series 10 approaches, it’s important to note that a major functionality will be absent: blood oxygen level monitoring.
For customers in the U.S., this means the Apple Watch Series 10 will not support the Blood Oxygen app. As noted in a footnote on Apple’s official Store page, “The ability to measure blood oxygen is no longer available on Apple Watch units sold by Apple in the United States beginning January 18, 2024. These are indicated with part numbers ending in LW/A.”
The issue stems from a patent dispute with a medical technology firm, Masimo, which has led to an ongoing legal battle over the blood oxygen sensor technology. Masimo alleges that Apple has infringed its patented wearable tech.
Reportedly, Masimo attempted to negotiate with Apple prior to the debut of the original Apple Watch, but the talks did not culminate in a deal. While the technology was under development back then, it only made its market debut with the Apple Watch Series 6.
A ruling from the U.S. International Trade Commission (ITC) found that Apple’s blood oxygen sensors violated Masimo’s patents, resulting in a temporary sales ban on affected Apple Watches in the U.S. Apple is actively working to appeal this ruling after being deemed to have partially infringed on Masimo’s patents.
At this point, it remains uncertain whether or when blood oxygen tracking will become available for the Apple Watch Series 10 in the U.S. The most likely path to reinstatement will depend on a favorable court decision for Apple.